Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly losses of $(0.18) per share. This is a 5.88 percent decrease over losses of $(0.17) per share from the same period last year.
Related Posts
UBS Maintains Buy on Carnival, Lowers Price Target to $12
UBS analyst Robin Farley maintains Carnival (NYSE:CCL) with a Buy and lowers the price target from $16 to $12.
Nikola Stock Is Moving Higher Monday: What’s Going On?
Nikola Corp (NASDAQ: NKLA) shares are trading higher. The company announced the appointment of a new chief operating officer Monday morning.
What’s Going On With Shares Of Bitcoin Miner Hut 8 Monday?
Hut 8 Corp (NASDAQ: HUT) shares are trading flat.